1 – 2 of 2
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1
(
- Contribution to journal › Article
- 2020
-
Mark
MNK2 governs the macrophage antiinflammatory phenotype
2020) In Proceedings of the National Academy of Sciences of the United States of America 117(44). p.27556-27565(
- Contribution to journal › Article